Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Handbook of Experimental Pharmacology
|
April 21, 2018
Multifunctional Opioid Ligands
Jessica P Anand, Deanna Montgomery
Psychopharmacology
|
April 28, 2016
The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice
Jessica P Anand, Brett T Boyer, Henry I Mosberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 21, 2025
Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia
Catherine Demery, Sierra C Moore, Erica S Levitt, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Xylazine Exacerbates Fentanyl-Induced Respiratory Depression and Bradycardia
Catherine Demery-Poulos, Sierra C Moore, Erica S Levitt, et al.
Chemical Biology & Drug Design
|
August 14, 2012
Modulation of opioid receptor ligand affinity and efficacy using active and inactive state receptor models
Jessica P Anand, Lauren C Purington, Irina D Pogozheva, et al.
The Journal of Biological Chemistry
|
June 23, 2009
Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2
Adam J Kuszak, Sethuramasundaram Pitchiaya, Jessica P Anand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 18, 2026
Enhanced antinociception of mixed efficacy opioid peptidomimetics through P-glycoprotein modulation
Jessica P Anand, Kelsey E Kochan, Deanna Montgomery, et al.
Journal of Medicinal Chemistry
|
March 30, 2019
Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability
Sean P Henry, Thomas J Fernandez, Jessica P Anand, et al.
ACS Chemical Neuroscience
|
May 5, 2015
Asymmetric synthesis and in vitro and in vivo activity of tetrahydroquinolines featuring a diverse set of polar substitutions at the 6 position as mixed-efficacy μ opioid receptor/δ opioid receptor ligands
Aaron M Bender, Nicholas W Griggs, Jessica P Anand, et al.
Journal of Medicinal Chemistry
|
March 20, 2014
Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance
Henry I Mosberg, Larisa Yeomans, Jessica P Anand, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Handbook of Experimental Pharmacology
|
April 21, 2018
Multifunctional Opioid Ligands
Jessica P Anand, Deanna Montgomery
Psychopharmacology
|
April 28, 2016
The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice
Jessica P Anand, Brett T Boyer, Henry I Mosberg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 21, 2025
Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia
Catherine Demery, Sierra C Moore, Erica S Levitt, et al.
Biorxiv : the Preprint Server for Biology
|
September 4, 2024
Xylazine Exacerbates Fentanyl-Induced Respiratory Depression and Bradycardia
Catherine Demery-Poulos, Sierra C Moore, Erica S Levitt, et al.
Chemical Biology & Drug Design
|
August 14, 2012
Modulation of opioid receptor ligand affinity and efficacy using active and inactive state receptor models
Jessica P Anand, Lauren C Purington, Irina D Pogozheva, et al.
The Journal of Biological Chemistry
|
June 23, 2009
Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2
Adam J Kuszak, Sethuramasundaram Pitchiaya, Jessica P Anand, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 18, 2026
Enhanced antinociception of mixed efficacy opioid peptidomimetics through P-glycoprotein modulation
Jessica P Anand, Kelsey E Kochan, Deanna Montgomery, et al.
Journal of Medicinal Chemistry
|
March 30, 2019
Structural Simplification of a Tetrahydroquinoline-Core Peptidomimetic μ-Opioid Receptor (MOR) Agonist/δ-Opioid Receptor (DOR) Antagonist Produces Improved Metabolic Stability
Sean P Henry, Thomas J Fernandez, Jessica P Anand, et al.
ACS Chemical Neuroscience
|
May 5, 2015
Asymmetric synthesis and in vitro and in vivo activity of tetrahydroquinolines featuring a diverse set of polar substitutions at the 6 position as mixed-efficacy μ opioid receptor/δ opioid receptor ligands
Aaron M Bender, Nicholas W Griggs, Jessica P Anand, et al.
Journal of Medicinal Chemistry
|
March 20, 2014
Development of a bioavailable μ opioid receptor (MOPr) agonist, δ opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance
Henry I Mosberg, Larisa Yeomans, Jessica P Anand, et al.
Page
of 3